The Warfarin Sodium Tablets, cataloged under National Stock Number 6505-01-153-3886, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Taro Pharmaceuticals U.s.a., Inc.. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 6 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 5 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-153-3886 |
| Primary Part Number | NDC51672-4034-01 |
| Item Name | Warfarin Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Taro Pharmaceuticals U.s.a., Inc. |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Content Quantity | 100.000 TABLETS |
| Active Medicament Medicinal Strength | 7.500 MILLIGRAMS WARFARIN SODIUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| COUMADIN TABLETS | Bristol-Myers Squibb Pharma Company (USA) |
| COUMADIN | Bristol-Myers Squibb Pharma Company (USA) |
| NDC51672-4034-01 PRIMARY | Taro Pharmaceuticals U.s.a., Inc. (USA) |
| NDC51407-0791-01 PRIMARY | Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc (USA) |
| NDC76282-0334-01 | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals (USA) |
| NDC00093-1723-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
NSN 6505-01-153-3886 is a Warfarin Sodium Tablets, manufactured by Taro Pharmaceuticals U.s.a., Inc., classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-153-3886 has 6 cross-referenced part numbers: COUMADIN TABLETS (Bristol-Myers Squibb Pharma Company), COUMADIN (Bristol-Myers Squibb Pharma Company), NDC51672-4034-01 (Taro Pharmaceuticals U.s.a., Inc.), NDC51407-0791-01 (Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc), NDC76282-0334-01 (Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals) and 1 more.
There are 5 known substitutes for 6505-01-153-3886: 6505-00-973-8502, 6505-00-982-4230, 6505-01-049-1815 and 2 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC51672-4034-01: Primary Container Type: BOTTLE; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 100.000 TABLETS; Special Features: CRYSTALLINE FORM. 6 total characteristics are documented in the Federal Logistics Information System.